Document Actions
CMS Dares Critics To Produce ESA Data
From The Cancer Letter, Sept. 28, 2007:
The agency that oversees the Medicare program declined to reconsider its coverage decision to restrict payment for erythropoiesis-stimulating agents in oncology._____
tags:
Friday, September 28, 2007
in
policy issues
| Permalink |
Comments (0)
trackback URL: http://www.cancerletter.com/tcl-blog/copy16_of_whats-going-on-with-nih/sbtrackback
Forgot your password?